```json
{
"content": [
{
"type": "paragraph",
"content": "North America leads the Insomnia Treatment Drugs market growth with a 35% share, driven by high adoption of advanced therapies, robust healthcare infrastructure, and significant R&D investments. The aging population and rising prevalence of sleep disorders further accelerate demand. Asia Pacific is the fastest-growing region at 12% CAGR, fueled by expanding healthcare access, growing awareness, and demographic shifts in countries like India and China."
},
{
"type": "paragraph",
"content": "Europe holds a 30% market share, supported by mature healthcare systems, favorable reimbursement policies, and a strong focus on mental health. Regulatory harmonization under the EMA ensures rapid drug approvals. In Latin America, 6% market share is attributed to rising urbanization and increasing investments in sleep clinics, though infrastructure gaps limit growth."
},
{
"type": "paragraph",
"content": The Middle East & Africa region accounts for 4% of the market, driven by urbanization and improving healthcare facilities in Gulf nations. However, socioeconomic disparities and underdeveloped healthcare ecosystems hinder broader adoption. Regional forecast models predict Asia Pacific will surpass Europe by 2030, propelled by ecosystem maturity and demographic tailwinds.
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 30 },
{ "name": "Asia Pacific", "value": 25 },
{ "name": "Latin America", "value": 6 },
{ "name": "Middle East & Africa", "value": 4 }
]
}
}
```
